Koninklijke Philips (PHG) Change in Accured Expenses (2009 - 2026)
Koninklijke Philips (PHG) recorded quarterly Change in Accured Expenses of $21.1 million in Q1 2026, down 66.47% quarter-over-quarter from $62.9 million in Q4 2025, and up 180.14% on a YoY basis from $7.5 million in Q1 2025.
Koninklijke Philips (PHG) Change in Accured Expenses (2009 - 2026) Analysis & Trends
Koninklijke Philips' Change in Accured Expenses history runs 18 years deep, the most recent figure standing at $21.1 million for Q1 2026.
- In Q1 2026, Change in Accured Expenses rose 180.14% year-over-year to $21.1 million; the TTM figure through Mar 2026 stood at $88.9 million (up 158.61% YoY), while the FY2024 annual figure was -$54.5 million, down 33.29% from the prior year.
- Change in Accured Expenses was $21.1 million for Q1 2026 at Koninklijke Philips, down from $62.9 million in the prior quarter.
- In the past five years, Change in Accured Expenses ranged from a high of $62.9 million in Q4 2025 to a low of -$124.8 million in Q2 2022.
- Historically, Change in Accured Expenses has averaged -$27.2 million across 5 years, with a median of -$26.3 million in 2025.
- The sharpest annual moves came in 2022 and 2025: Change in Accured Expenses sank 327.02% in 2022, then soared 215.34% in 2025.
- A 5-year view of Change in Accured Expenses shows it stood at -$85.7 million in 2022, then soared by 52.29% to -$40.9 million in 2023, then tumbled by 33.29% to -$54.5 million in 2024, then soared by 215.34% to $62.9 million in 2025, then slumped by 66.47% to $21.1 million in 2026.
- The last three Change in Accured Expenses figures came in at $21.1 million (Q1 2026), $62.9 million (Q4 2025), and $14.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | - |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | -654.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 703.00 Mn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | -512.00 Mn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | -347.10 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 21.07 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 145.10 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | -250.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 74.30 Mn |
| 10 | Zimmer Biomet Holdings | 17.18 Bn | 16.77 Bn | 1.51 Bn | -183.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 21.07 Mn |
| Mar 31, 2026 | 21.07 Mn |
| Dec 31, 2025 | 62.86 Mn |
| Dec 31, 2025 | 62.86 Mn |
| Sep 30, 2025 | 14.03 Mn |
| Sep 30, 2025 | 14.03 Mn |
| Jun 30, 2025 | -9.06 Mn |
| Jun 30, 2025 | -9.06 Mn |
| Mar 31, 2025 | -26.30 Mn |
| Mar 31, 2025 | -26.30 Mn |
| Dec 31, 2024 | -54.50 Mn |
| Dec 31, 2024 | -54.50 Mn |
| Sep 30, 2024 | -46.13 Mn |
| Sep 30, 2024 | -46.13 Mn |
| Jun 30, 2024 | -24.77 Mn |
| Jun 30, 2024 | -24.77 Mn |
| Mar 31, 2024 | -11.95 Mn |
| Mar 31, 2024 | -11.95 Mn |
| Dec 31, 2023 | -40.89 Mn |
| Dec 31, 2023 | -40.89 Mn |